Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers

• Fuhao Wang,
• Qingyu Huang,
• Shicheng Guo,
• Alberto Traverso,
• Alberto Traverso,
• Feifei Teng,
• Chao Liu

Affiliations

Fuhao Wang

Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Qingyu Huang

Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Shicheng Guo

Department of Medical Genetics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States

Alberto Traverso

Department of Radiation Oncology (Maastro Clinic), School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, Netherlands

Alberto Traverso

School of Medicine, Libera Università Vita-Salute San Raffaele, Milan, Italy

Feifei Teng

Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Chao Liu

Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China